Nov 20, 2018

PhRMA spread money far and wide in Trump's first year

PhRMA booked $456 million of revenue in 2017. Photo: Bob Herman/Axios

PhRMA, the pharmaceutical industry's main lobbying group, considerably bolstered its political and financial position during President Trump's first year in office, new federal tax filings show.

The bottom line: PhRMA directed tens of millions of dollars toward conservative think tanks, political groups of all stripes and patient advocates with the hope of convincing the public that the industry isn't "getting away with murder," as Trump put it, and that others are to blame for the country's drug pricing maze.

By the numbers: The world's largest drug companies are members of PhRMA, and they paid a lot more in membership dues last year.

  • PhRMA's total revenue in 2017 was $456 million, up 68% from 2016.
  • Membership dues rose 62% year over year to $396 million.

Where did that money go? Pretty much everywhere.

  • Federal and state lobbying increased 126% in 2017. Two large law firms, Covington & Burling and Arnold & Porter, combined to collect $8.6 million alone from PhRMA.
  • Tens of millions in grants were funneled to patient advocacy groups that often stay silent about rising drug prices. Some of the largest PhRMA-funded patient groups were the Addiction Policy Forum, the Leukemia & Lymphoma Society and the AIDS Institute.
  • PhRMA's advertising budget multiplied by almost 10 times. Ad agency Young & Rubicam and PR firm Porter Novelli cumulatively were paid $17 million.
  • Seven PhRMA executives made at least $1 million in 2017. PhRMA CEO Stephen Ubl made the most with almost $3.1 million, up 9% from his pay in 2016.

Politically motivated spending: PhRMA gave millions to political groups representing both parties and to conservative-leaning think tanks that embrace free-market policy ideas. 

  • The biggest recipient was America First Policies, a "dark money" conservative nonprofit that promotes Trump's agenda, which received $2.5 million. 
  • Other recipients of at least $1 million from PhRMA were the American Action Network and the National Republican Redistricting Trust — both on the political right — as well as Center Forward, a bipartisan political action committee pushing centrist reforms.

Yes, but: Other political beneficiaries included both the Republican ($325,000) and Democratic ($305,000) Governors Associations, as well as both candidates for Virginia governor last year (each received $20,000).

  • PhRMA also gave small political contributions to tons of state candidates across the nation — presumably ensuring friendly faces will be located in plenty of places.
  • Conservative ideology is obviously much more favorable to PhRMA, as it resists federal intervention in the marketplace. But the organization has clearly decided contributing to both parties is a worthwhile expenditure.

Be smart: PhRMA has always used its financial resources to influence state and federal policies that protect its members' profitable businesses, and the group arguably has more money to play with than ever.

  • But that didn't prevent PhRMA from being blindsided earlier this year when Congress shifted some Medicare costs to drug companies.

Go deeper

Scoop: Inside the Trump campaign's big hedge on Facebook

Illustration: Eniola Odetunde/Axios

The Trump campaign has invested most of its advertising budget to date on Facebook, testing thousands of versions of ads per day to maximize its spending.

But behind the scenes, a source familiar with the campaign tells Axios, the thinking has shifted: "As everyone can see, we still have strong spending on Facebook, but the percentage of our total media budget [on Facebook] is shrinking."

Trump's revenge tour has the House in its sights

Illustration: Aïda Amer/Axios. Photo: Saul Loeb/Getty Contributor

In the lead-up to the 2018 midterm elections — buoyed by Republican control of both chambers — President Trump viewed campaigning for the House as a lower-tier priority and instead poured his energy into rallying for the Senate.

But after the GOP reckoning in 2018, and experiencing firsthand how damaging a Democratic-led House has been to him, Trump is now personally invested in helping Republicans regain the majority in November, several people familiar with his thinking tell Axios.

Pelosi warns U.S. allies against working with China's Huawei

Nancy Pelosi, Feb. 16. Photo: Sven Hoppe/picture alliance via Getty Images

House Speaker Nancy Pelosi on Sunday cautioned U.S. allies against allowing Chinese telecommunications giant Huawei to develop their 5G networks, arguing at the Munich Security Conference that doing so is akin to “choosing autocracy over democracy," CNBC reports.

Why it matters: Pelosi's hawkish stance marks a rare area of agreement with the Trump administration, which believes Huawei is a national security threat because the Chinese government may be capable of accessing its equipment for espionage.

Go deeperArrow4 hours ago - World